MoonLake Immunotherapeutics News

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 15 15:08

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 14 17:08

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 20, 2023 15:16

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 19, 2023 15:34

MoonLake Immunotherapeutics | EFFECT: Others

Sep 11, 2023 23:15

MoonLake Immunotherapeutics | 424B5: Prospectus

Jun 29, 2023 15:02

MoonLake Immunotherapeutics | 424B3: Prospectus

Jun 27, 2023 15:28

MoonLake Immunotherapeutics | 424B5: Prospectus

Jun 26, 2023 15:23

MoonLake Immunotherapeutics | 424B5: Prospectus

May 11, 2023 15:20

MoonLake Immunotherapeutics | EFFECT: Others

May 9, 2023 23:15

MoonLake Immunotherapeutics | EFFECT: Others

May 4, 2023 23:15

MoonLake Immunotherapeutics | 424B3: Prospectus

Mar 28, 2023 15:05

MoonLake Immunotherapeutics | EFFECT: Others

Mar 27, 2023 23:15

MoonLake Immunotherapeutics | 424B3: Prospectus

Nov 14, 2022 07:32

MoonLake Immunotherapeutics | 424B3: Prospectus

Aug 12, 2022 15:52

MoonLake Immunotherapeutics | EFFECT: Others

Aug 2, 2022 23:15

MoonLake Immunotherapeutics | 424B3: Prospectus

Aug 2, 2022 15:45

Helix Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 24, 2022 15:52

Helix Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 24, 2021 13:05

Helix Acquisition Corp | 424B4: Prospectus

Oct 21, 2020 16:06